Annual Total Debt
$2.44 M
+$1.69 M+225.01%
December 31, 2022
Summary
- As of February 8, 2025, NAVB annual total debt is $2.44 million, with the most recent change of +$1.69 million (+225.01%) on December 31, 2022.
- During the last 3 years, NAVB annual total debt has risen by +$1.37 million (+127.88%).
- NAVB annual total debt is now -96.05% below its all-time high of $61.60 million, reached on December 31, 2016.
Performance
NAVB Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.26 M
-$78.80 K-5.89%
September 30, 2023
Summary
- As of February 8, 2025, NAVB quarterly total debt is $1.26 million, with the most recent change of -$78.80 thousand (-5.89%) on September 30, 2023.
- Over the past year, NAVB quarterly total debt has dropped by -$78.80 thousand (-5.89%).
- NAVB quarterly total debt is now -97.97% below its all-time high of $62.20 million, reached on September 30, 2016.
Performance
NAVB Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
NAVB Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +225.0% | -5.9% |
| 3 y3 years | +127.9% | -5.9% |
| 5 y5 years | -20.1% | -5.9% |
NAVB Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +225.0% | -48.3% | +289.6% |
| 5 y | 5-year | at high | +225.0% | -48.3% | +289.6% |
| alltime | all time | -96.0% | +3803.2% | -98.0% | -100.0% |
Navidea Biopharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.26 M(-5.9%) |
| Jun 2023 | - | $1.34 M(-42.3%) |
| Mar 2023 | - | $2.32 M(-4.8%) |
| Dec 2022 | $2.44 M(+225.0%) | $2.44 M(+33.8%) |
| Sep 2022 | - | $1.82 M(+116.5%) |
| Jun 2022 | - | $840.80 K(+160.0%) |
| Mar 2022 | - | $323.40 K(-56.8%) |
| Dec 2021 | $749.40 K(-43.9%) | $749.40 K(+97.0%) |
| Sep 2021 | - | $380.50 K(-12.4%) |
| Jun 2021 | - | $434.40 K(-38.3%) |
| Mar 2021 | - | $704.20 K(-47.3%) |
| Dec 2020 | $1.34 M(+25.0%) | $1.34 M(+29.5%) |
| Sep 2020 | - | $1.03 M(-8.0%) |
| Jun 2020 | - | $1.12 M(+17.2%) |
| Mar 2020 | - | $957.60 K(-10.4%) |
| Dec 2019 | $1.07 M(+18.1%) | $1.07 M(+29.6%) |
| Sep 2019 | - | $824.70 K(-12.7%) |
| Jun 2019 | - | $944.80 K(-16.2%) |
| Mar 2019 | - | $1.13 M(+24.5%) |
| Dec 2018 | $905.30 K(-70.3%) | $905.30 K(-67.3%) |
| Sep 2018 | - | $2.77 M(-1.8%) |
| Jun 2018 | - | $2.82 M(-4.7%) |
| Mar 2018 | - | $2.96 M(-2.9%) |
| Dec 2017 | $3.05 M(-95.1%) | $3.05 M(+53.9%) |
| Sep 2017 | - | $1.98 M(-0.8%) |
| Jun 2017 | - | $2.00 M(-5.0%) |
| Mar 2017 | - | $2.10 M(-96.6%) |
| Dec 2016 | $61.60 M(+0.9%) | $61.60 M(-1.0%) |
| Sep 2016 | - | $62.20 M(+1.7%) |
| Jun 2016 | - | $61.17 M(+0.5%) |
| Mar 2016 | - | $60.85 M(-0.4%) |
| Dec 2015 | $61.08 M(+80.5%) | $61.08 M(-0.3%) |
| Sep 2015 | - | $61.28 M(+3.6%) |
| Jun 2015 | - | $59.17 M(+67.1%) |
| Mar 2015 | - | $35.40 M(+4.6%) |
| Dec 2014 | $33.83 M(+22.3%) | $33.83 M(+4.2%) |
| Sep 2014 | - | $32.48 M(+4.0%) |
| Jun 2014 | - | $31.22 M(+0.9%) |
| Mar 2014 | - | $30.94 M(+11.8%) |
| Dec 2013 | $27.67 M(+185.6%) | $27.67 M(-0.4%) |
| Sep 2013 | - | $27.78 M(+1.7%) |
| Jun 2013 | - | $27.31 M(+109.9%) |
| Mar 2013 | - | $13.01 M(+34.3%) |
| Dec 2012 | $9.69 M(+50.0%) | $9.69 M(+60.9%) |
| Sep 2012 | - | $6.02 M(-8.4%) |
| Jun 2012 | - | $6.57 M(+1.0%) |
| Mar 2012 | - | $6.51 M(+0.8%) |
| Dec 2011 | $6.46 M(>+9900.0%) | $6.46 M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | $9100.00(-74.7%) |
| Mar 2011 | - | $36.00 K(-42.3%) |
| Dec 2010 | $62.40 K(-99.4%) | $62.40 K(+177.3%) |
| Sep 2010 | - | $22.50 K(-11.4%) |
| Jun 2010 | - | $25.40 K(-99.8%) |
| Mar 2010 | - | $10.98 M(+0.3%) |
| Dec 2009 | $10.95 M(+80.0%) | $10.95 M(-0.1%) |
| Sep 2009 | - | $10.95 M(+76.0%) |
| Jun 2009 | - | $6.22 M(+1.7%) |
| Mar 2009 | - | $6.12 M(+0.7%) |
| Dec 2008 | $6.08 M | $6.08 M(+5.1%) |
| Sep 2008 | - | $5.79 M(+2.3%) |
| Jun 2008 | - | $5.66 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $5.49 M(+0.9%) |
| Dec 2007 | $5.45 M(-19.1%) | $5.45 M(-11.5%) |
| Sep 2007 | - | $6.15 M(+1.0%) |
| Jun 2007 | - | $6.09 M(-3.2%) |
| Mar 2007 | - | $6.29 M(-6.5%) |
| Dec 2006 | $6.73 M(+8.1%) | $6.73 M(+4.5%) |
| Sep 2006 | - | $6.44 M(+1.2%) |
| Jun 2006 | - | $6.36 M(+1.2%) |
| Mar 2006 | - | $6.29 M(+1.0%) |
| Dec 2005 | $6.23 M(+7.7%) | $6.23 M(+5.3%) |
| Sep 2005 | - | $5.91 M(+0.8%) |
| Jun 2005 | - | $5.87 M(+0.6%) |
| Mar 2005 | - | $5.83 M(+0.9%) |
| Dec 2004 | $5.78 M(+748.8%) | $5.78 M(+2849.7%) |
| Sep 2004 | - | $195.90 K(-1.5%) |
| Jun 2004 | - | $198.90 K(-20.2%) |
| Mar 2004 | - | $249.10 K(-63.4%) |
| Dec 2003 | $680.80 K(+253.8%) | $680.80 K(+57.5%) |
| Sep 2003 | - | $432.20 K(-0.6%) |
| Jun 2003 | - | $434.90 K(+296.8%) |
| Mar 2003 | - | $109.60 K(-43.0%) |
| Dec 2002 | $192.40 K(-1.2%) | $192.40 K(-90.5%) |
| Sep 2002 | - | $2.02 M(+91.9%) |
| Jun 2002 | - | $1.05 M(+742.3%) |
| Mar 2002 | - | $125.20 K(-35.7%) |
| Dec 2001 | $194.80 K(+30.2%) | $194.80 K(+442.6%) |
| Sep 2001 | - | $35.90 K(-33.6%) |
| Jun 2001 | - | $54.10 K(-47.2%) |
| Mar 2001 | - | $102.40 K(-31.6%) |
| Dec 2000 | $149.60 K(-96.7%) | $149.60 K(+219.0%) |
| Sep 2000 | - | $46.90 K(-83.1%) |
| Jun 2000 | - | $276.80 K(-13.4%) |
| Mar 2000 | - | $319.50 K(-75.4%) |
| Dec 1999 | $4.54 M(+202.9%) | - |
| Jun 1999 | - | $1.30 M(-7.1%) |
| Mar 1999 | - | $1.40 M(-6.5%) |
| Dec 1998 | $1.50 M(-38.3%) | $1.50 M(-71.7%) |
| Sep 1998 | - | $5.30 M(+1.9%) |
| Jun 1998 | - | $5.20 M(+10.6%) |
| Mar 1998 | - | $4.70 M(+93.6%) |
| Dec 1997 | $2.43 M(+102.3%) | $2.43 M(+15.6%) |
| Sep 1997 | - | $2.10 M(+5.0%) |
| Jun 1997 | - | $2.00 M(+42.9%) |
| Mar 1997 | - | $1.40 M(+16.7%) |
| Dec 1996 | $1.20 M(-20.0%) | $1.20 M(-29.4%) |
| Sep 1996 | - | $1.70 M(+112.5%) |
| Jun 1996 | - | $800.00 K(-11.1%) |
| Mar 1996 | - | $900.00 K(-40.0%) |
| Dec 1995 | $1.50 M(-6.3%) | $1.50 M(0.0%) |
| Sep 1995 | - | $1.50 M(+200.0%) |
| Jun 1995 | - | $500.00 K(0.0%) |
| Mar 1995 | - | $500.00 K(-68.8%) |
| Dec 1994 | $1.60 M(+433.3%) | $1.60 M(+166.7%) |
| Sep 1994 | - | $600.00 K(0.0%) |
| Jun 1994 | - | $600.00 K(+50.0%) |
| Mar 1994 | - | $400.00 K(+33.3%) |
| Dec 1993 | $300.00 K(+200.0%) | $300.00 K(+200.0%) |
| Sep 1993 | - | $100.00 K(>+9900.0%) |
| Jun 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00(-100.0%) |
| Dec 1992 | $100.00 K | $100.00 K(>+9900.0%) |
| Sep 1992 | - | $0.00 |
FAQ
- What is Navidea Biopharmaceuticals annual total debt?
- What is the all time high annual total debt for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual total debt year-on-year change?
- What is Navidea Biopharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly total debt year-on-year change?
What is Navidea Biopharmaceuticals annual total debt?
The current annual total debt of NAVB is $2.44 M
What is the all time high annual total debt for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual total debt is $61.60 M
What is Navidea Biopharmaceuticals annual total debt year-on-year change?
Over the past year, NAVB annual total debt has changed by +$1.69 M (+225.01%)
What is Navidea Biopharmaceuticals quarterly total debt?
The current quarterly total debt of NAVB is $1.26 M
What is the all time high quarterly total debt for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly total debt is $62.20 M
What is Navidea Biopharmaceuticals quarterly total debt year-on-year change?
Over the past year, NAVB quarterly total debt has changed by -$78.80 K (-5.89%)